153034-80-1

Basic information

• Product Name: 2-FLUORO-4-IODO-3-PICOLINE
• Synonyms: 2-FLUORO-4-IODO-3-PICOLINE;2-Fluoro-4-iodo-3-methylpyridine
• CAS NO: 153034-80-1
• Molecular Formula: C₆H₅FIN
• Molecular Weight: 237.01
• Product Categories: Pyridine;Pyridines;Boronic Acid
• Mol File: 153034-80-1.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 244℃
• Flash Point: 101℃
• Appearance: /
• Density: 1.892
• Vapor Pressure: 0.05mmHg at 25°C
• Refractive Index: 1.587
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: -1.53±0.18(Predicted)
• CAS DataBase Reference: 2-FLUORO-4-IODO-3-PICOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-FLUORO-4-IODO-3-PICOLINE(153034-80-1)
• EPA Substance Registry System: 2-FLUORO-4-IODO-3-PICOLINE(153034-80-1)

Safety Data

• Hazardous Substances Data: 153034-80-1(Hazardous Substances Data)

Usage

General Description

2-FLUORO-4-IODO-3-PICOLINE is a chemical compound with the molecular formula C6H4FNI and a molecular weight of 240.91 g/mol. It is a complex heterocyclic compound containing a fluorine atom, an iodine atom, and a pyridine ring. The compound is mainly used as a building block for pharmaceuticals and agrochemicals, as well as in the production of various organic and medicinal compounds. It is also used as a reagent in chemical synthesis and research. Due to its unique chemical structure and reactivity, 2-FLUORO-4-IODO-3-PICOLINE has a wide range of applications in the fields of chemistry and chemical engineering.

InChI:InChI=1/C6H5FIN/c1-4-5(8)2-3-9-6(4)7/h2-3H,1H3

Upstream product

• 372-48-5 2-fluoropyridine 
• 74-88-4 methyl iodide 
• 22282-70-8 2-fluoro-4-iodopyridine 
• 113975-22-7 2-fluoro-3-iodopyridine 

Downstream Products

• 171366-22-6 (S)-2-(2-Fluoro-3-methyl-pyridin-4-yl)-2-hydroxy-butyric acid (1R,2S)-2-(1-methyl-1-phenyl-ethyl)-cyclohexyl ester 
• 55854-89-2 8-methyl-7-propionylindolizino[1,2-b]quinoline-9(11H)-one 
• 171366-23-7 (S)-2-(3-Bromomethyl-2-fluoro-pyridin-4-yl)-2-hydroxy-butyric acid (1R,2S)-2-(1-methyl-1-phenyl-ethyl)-cyclohexyl ester 
• 171366-24-8 (S)-2-(3-Acetoxymethyl-2-fluoro-pyridin-4-yl)-2-hydroxy-butyric acid (1R,2S)-2-(1-methyl-1-phenyl-ethyl)-cyclohexyl ester 
• 1240911-03-8 2-(2-fluoro-3-methylpyridin-4-yl)-5-{[4-(1H-pyrazol-1-yl)phenyl]methyl}-2,5-dihydro-3H-pyrazolo[4,3-c]cinnolin-3-one 
• 1227571-05-2 4-iodo-3-methylpyridin-2(1H)-one 
• 1312479-36-9 ethyl 2-methyl-4-(3-methyl-2-oxo-4-phenylpyridin-1(2H)-yl)-2-(methylsulfonyl)butanoate 
• 1312479-37-0 2-methyl-4-(3-methyl-2-oxo-4-phenylpyridin-1(2H)-yl)-2-(methylsulfonyl)butanoic acid 
• 1312479-38-1 2-methyl-4-(3-methyl-2-oxo-4-phenylpyridin-1(2H)-yl)-2-(methylsulfonyl)-N-(tetrahydro-2H-pyran-2-yloxy)butanamide 
• 1312473-93-0 N-hydroxy-2-methyl-4-(3-methyl-2-oxo-4-phenylpyridin-1(2H)-yl)-2-(methylsulfonyl)butanamide 
• 1334589-84-2 methyl 3-(4-((2-fluoro-3-methylpyridin-4-yl)ethynyl)phenyl)-propanoate 
• 1334589-71-7 3-(4-((2-fluoro-3-methylpyridin-4-yl)ethynyl)phenyl)propanoic acid 
• 1358778-33-2 (2R)-N-hydroxy-2-methyl-4-(3-methyl-2-oxo-4-phenylpyridin-1(2H)-yl)-2-(methylsulfonyl)butanamide 
• 1358778-36-5 (2R)-2-methyl-4-(3-methyl-2-oxo-4-phenylpyridin-1(2H)-yl)-2-(methylsulfonyl)-N-(tetrahydro-2H-pyran-2-yloxy)butanamide 

Relevant articles and documents

HETEROCYCLIC INHIBITORS OF PTPN11

The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their applica

PYRROLIDINE OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to pyrrolidine compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

Traceless solid-phase synthesis of mappicine ketone library via multiple chemoselective palladium-catalyzed reactions on benzenesulfonate linker

We report here a solid-phase synthesis of a library of mappicine ketone, a leading antiviral compound with activity against herpes viruses and human cytomegalovirus. The synthesis is based on multiple chemoselective palladium-catalyzed reactions involving